Navigation Links
Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials

Ace Biosciences, Ace393, the World's First Commercial Vaccine for Travellers' Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials

Trial confirms good safety profile and strong immunogenicity

ODENSE, Denmark, March 28, 2007 -ACE BioSciences A/S, the infectious diseases company is pleased to announce the successful completion of Phase I clinical trials with its lead product, ACE393, the world's first commercial vaccine for Travellers' Diarrhoea (TD) caused by Campylobacter infection.

ACE393 is an injectable vaccine designed to combat the bacterium Campylobacter jejuni, one of the greatest causes of bacterial diarrhoeal infections in the developed world. The two stage, double blind, randomised, placebo-controlled trial confirmed that the vaccine was very well tolerated and that the strongest immune response was stimulated by the highest dose when administered in two doses either two or three weeks apart, with 100% of subjects responding. Adverse reactions were transient local site reaction and headaches in some subjects.

Dr Philippe Reboud, (Mediscis Phase I clinical unit) the study_s Principal Investigator commented "These are very satisfying results. The study clearly confirms the vaccine's safety and tolerability. Furthermore, at the 250µg dose, ACE393 stimulates a four fold increase in IgG antibody titre in all subjects, indicating strong immunogenicity (ability to stimulate an immune response). In the past it has proved too challenging to develop an effective vaccine against Campylobacter infection and Travellers' Diarrhoea has been difficult to prevent, leading to the incidence of serious long-term post infection complications such as Guillain Barre Syndrome and reactive arthritis in a few patients. However, thanks to the innovative approach taken by ACE BioSciences, this looks set to change."

Ms Ingelise Saunders, ACE BioSciences, C
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
2. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
6. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
7. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
8. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
9. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
10. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
11. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy

Post Your Comments:
(Date:11/20/2009)... , , MEMPHIS, Tenn., Nov. 20 /PRNewswire-...rthopaedics Division is pleased to announce the si...e United States Department of Defense that may lea...tended to revolutionize the treatment of the limbs..., Last year, the Defense Advanced Research Projec...
(Date:11/19/2009)... , , LYON, France, Nov. 19 ...tes supplying dangerous and illegal medicines, Ope...dinated by INTERPOL and the World Health Organizat...eiting Taskforce (IMPACT) to highlight the dangers...lobal initiative resulted in a series of arrests a...
(Date:11/19/2009)... , , DAYTON, Ohio, Nov. 19 ...will be partnering with leading Canadian medical i...w Enhanced Chest Imaging and OnGuard Chest Xray CA... based Riverain Medical,s products to the Canadian...eputable sales channel. ,, SoftView Enhanced Ch...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Emerging Woman Business Owner of the Year Winner Offers 5 Tips to New Women Business Owners 52074 1Emerging Woman Business Owner of the Year Winner Offers 5 Tips to New Women Business Owners 52074 2OpenQ Posts a 200 25 Revenue Growth in the First Half of 2009 13081 1OpenQ Posts a 200 25 Revenue Growth in the First Half of 2009 13081 2Interaction Associates and The Interaction Institute for Social Change Present at the Greater Than Conference 52071 1Interaction Associates and The Interaction Institute for Social Change Present at the Greater Than Conference 52071 2Interaction Associates and The Interaction Institute for Social Change Present at the Greater Than Conference 52071 3
...Pa. and LYON, France, Aug. 1 Sanofi,Pasteur, the ...hipping,influenza vaccine (Fluzone(R), Influenza V...09 season. The first 1.3 million doses of influenz...ting clearance of the,2008-2009 formulation by the...4, 2008., Vaccine shipments to health-care provid...
...me First Effective Drug for Rare Genetic Disorder ... have used,a drug to achieve normal levels of bloo...abnormally high insulin levels. If this approach,s...edicine for children,with congenital hyperinsulini...ease in which insulin levels become dangerously hi...
Other Medicine Technology:Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 4Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 5Treatment Corrects Severe Insulin Imbalance in Animal Studies 2Treatment Corrects Severe Insulin Imbalance in Animal Studies 3
(Date:11/21/2009)... Linwood Group ask whether there is a secre...d? , London, UK (PRWEB) N... up to one in three of the adult UK population dri...g alcohol-related liver disease*, it is hardly a s...bilitation programmes and residential centres for ...
(Date:11/20/2009)... Mass., Nov. 20 Following a recall...ny removed from sale Shedd,s Country Crock ® ...,s Country Crock ® Side Dishes DELUXE Four Ch... ,, The following code dates and UPCs are affec...es DELUXE Cheddar Broccoli Rice 21 oz, UPC 0274002...
(Date:11/20/2009)...HAIFA, Israel, November 20 /PRNewswire-FirstCall/ ... http://www.CVSLMEDICAL.COM , a leading,developer...day announced that,the company,s Board of Director...urope, Canada and the Far East for its proprietary...for all angioplasty (PCTA) procedures. , ...
(Date:11/20/2009)...f exposure to formaldehyde used for embalming in t...sed risk of death from myeloid leukemia, according...e Journal of the National Cancer Institute . , ...lymphohematopoietic malignancies and brain cancer ...workers, all of whom may have worked with formalde...
(Date:11/20/2009)...to one-third buying 90-day supply, study finds , ...ing a three-month supply of prescription drugs is ...pply, according to a new study. , U.S. research...rugs between 2000 and 2005, and found that patient...-month supply saved an average 29 percent in out-o...
Breaking Medicine News(10 mins):Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Three-Month Supply Lowers Drug Costs 2
...g islands in the Indian Ocean such as Mauritius ha...s, which has claimed 77 lives so far, according to... is characterized by fever, joint and muscle pain,...ersity of Lausanne, Switzerland have reported the ...
...0 people in the U.S. are suffering from long-term ...currences taking place each year//. One stud...of Neuroscience appears to be on the right track t...ld be a return of functional activity. John ...
...ern South Africa turn to nature when seeking to ac...a, it emerged in news reports//. The root of ...ound in the villages of the Venda district near th...ther traditional drinks has been shown to relax th...
...to measure the presence and severity of involuntar...kinson's disease is being developed// and a couple... Michael J. Fox Foundation for this purpose. ...oetz, Director of Movement Disorders of Rush Unive...
...alone are twice as likely to have serious heart pr...w study//. According to a study published in ...Danish researchers surveyed around 1,38,000 adults... people who live alone. Doctors in India bel...
...oddlers should not be blamed on family environment...ays a study// that would come as a reassurance to ...ethon Institute for Child Health Research in Austr.... The studied children were from infancy to ...
Other Medicine News:Health News:New Method For Measuring Dyskinesia In Parkinson's Being Developed 2Health News:Toddlers' Delayed Speech not Due to Parenting Faults 2
Stat Profile® pHOx® CO-Oximeter
ACCU-DISC™ Pressure Monitoring System
...d-through motion and low perfusion pulse oximetry,...kthrough designs, including sensors with built-in ... that automatically tells the oximeter which monit...ensors made specifically for the patients they are...
ImmunoWELL Mumps Virus IgG Test
Medicine Products: